Keywords: USA, FDA, Pfizer, Wyeth, Prevnar 13, Sales forecasts

Pfizer gets US FDA approval for Prevnar 13, a Wyeth drug with blockbuster sales outlook

Article | 25 February 2010

Print This

The US Food and Drug Administration yesterday gave its approval for global drug behemoth Pfizer’s Prevnar 13, a pneumococcal 13-valent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in